
Al-Ola Abdallah and Jose Sandoval Sus
Aug 8, 2025, 02:29
Al-Ola Abdallah: Challenges For CAR T-cell Therapies in Large B-Cell Lymphoma
Al-Ola Abdallah, Associate Professor Of Medicine at University of Kansas Medical Center, shared a post on LinkedIn:
“Identifying Limitations to CAR T-Cell Therapies in Large B-Cell Lymphoma
Barriers to access and financial toxicities are challenges that must be addressed for CAR T-cell therapies in LBCL, according to Jose Sandoval Sus, at the 2025 National Immune Cell Effector Therapy (ICE_T) conference in Orlando, Florida via Cancer Network.”
More posts featuring Al-Ola Abdallah on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 10, 2025, 13:44
Aug 10, 2025, 12:46
Aug 10, 2025, 12:39
Aug 10, 2025, 12:29